Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...
Hosted on MSN
AI is helping doctors repurpose old drugs for new cures: 'The solution is in your neighborhood pharmacy'
When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...
Using AI, CDT Equity Inc. identifies a novel therapeutic indication for its lead programmes, supported by successful pre-clinical trial data NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 26, 2025 ...
Algorithms used for consumer predictions are being retooled to help identify which medicines are optimal and may carry hidden risks for patients. Researchers from Monash University used a different ...
Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
The collaboration will combine Syngene’s preclinical development expertise with VivaMed's AI-generated therapeutic hypotheses.
Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.
IAN Alpha Fund, the 2nd in the series of IAN Group’s VC funds, along with Speciale Invest, has co-led a ₹70 crore Series A funding round in Peptris, a Bengaluru-based AI-powered drug discovery company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results